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Summary 
To seek direct evidence for the notion that stem cells in the thymus need to be constantly replenished 
from the bone marrow (BM), fetal (day 15) thymuses from normal BALB/c mice were grafted 
into T  and B cell-deficient C.B-17 SCID mice (both H-2  d, I-E+).  The thymus grafts in these 
mice showed normal  thymopoiesis for the first 3 wk postgrafting but then developed sudden 
atrophy with near complete loss of CD4+8 + cells by 4-5 wk. Such atrophy was not seen when 
the thymus-grafted mice were cotransplanted with normal BM cells. The lymph nodes of SCID 
mice receiving thymus grafts alone contained mature T  cells but virtually no B cells. This lack 
of B cells was associated with aberrant  I-E-restricted Vfl deletion:  the depletion of Vfl3 + and 
Vfl5 + T  cells  was near complete,  whereas Vflll + cells  showed only marginal  depletion. 
N 
'eonatal  thymus  grafts  (TG) 1 placed  in  normal  or 
thymectomized mice undergo considerable  enlargement 
and remain functional for prolonged periods (1, 2). The cells 
proliferating in the TG are initially of donor origin but are 
rapidly replaced by host-derived cells. This transition is com- 
plete by 1 mo posttransfer.  Similarly,  intrathymic injection 
of  CD4-8-  thymic  stem  cells  results  in  only  transient 
thymopoiesis by donor-derived cells (3-5). These data imply 
that the self-renewing capacity of thymic stem cells is limited 
and that maintenance of thymic function depends on a con- 
tinuous inflow of stem cells from the bone marrow (BM). 
A  corollary to this notion is that  depriving  the thymus 
of an exogenous source of functional stem cells would lead 
to rapid atrophy.  This prediction can be tested by placing 
TG in SCID mice (6). These mice have an autosomal reces- 
sive mutation that prevents the formation of T  and B cells; 
T cell differentiation in SCID mice proceeds only to the stage 
of CD4-8-  thymocytes. We show here that day 15 BALB/c 
fetal TG placed in H-2-compatible adult C.B-17 SCID mice 
exhibit  normal  thymopoiesis  for 3  wk but  then  undergo 
sudden  atrophy  with  selective disappearance  of CD4 +  8 + 
cells. The LN of these mice contain large numbers of T cells 
but virtually no B cells. The absence of B cells is associated 
with  aberrant  Vfl deletion. 
1 Abbreviations used in this paper: B/c, BALB/c; TG, thymus grafts or 
thymus grafted. 
Materials and Methods 
M/ca  C.B-17  SCID mice (6) and other mice were obtained from 
the breeding colony of the Scripps Research Institute.  SCID mice 
were  maintained  under  pathogen-free  conditions.  Note  that 
C.B-17 and BALB/c are identical except for an Ig allotype difference. 
Thymus Grafting.  Day 15 fetal thymuses from timed-pregnant 
mice were inserted under the kidney capsule (four lobes/recipient) 
of young adult SCID mice using standard procedures. Some of the 
grafted mice received ",,5 x  l& T cell-depleted normal donor BM 
cells (7) intravenously within  1 d of grafting. 
Flow Cytometry.  Thymus and/or LN cells were stained for ex- 
pression ofCD4 (GK1.5), CD8 (53-5.7, 3.168, or YTS 169), c~/fl 
TCR (H57-597), IL-2R (7D4), B220 (14.8), CD45RB (23G2), Thy- 
1.1 (19E12), and TCR V33 (KJ25), -5 (MR9.4), -8 (F23.2), and 
-11 (RR3-15), as described elsewhere (7-10), using two- or three- 
color immunofluorescence and analysis on a FACScan  |  flow cytom- 
eter (Becton Dickinson & Co., Mountain View, CA). Briefly, cells 
were double stained for CD4 and CD8 using PE-conjugated anti- 
CD4 mAb plus biotinylated  anti-CD8 mAb followed by FITC- 
conjugated streptavidin (Zymed Laboratories, San Francisco, CA). 
For other markers, cells were stained with unconjugated  hamster 
(anti-cfffl  TCR)  or rat  (anti-Ib2R,  anti-B220,  anti-CD45RB) 
mAbs followed by FITC anti-hamster or -rat IgG reagents (Jackson 
ImmunoResearch, West Grove, PA), rat serum, and PE-conjugated 
anti-CD4  and/or  anti-CD8  mAbs.  For  TCR V3  staining, bi- 
otinylated mAbs were used with PE-conjugated anti-CD4 mAb 
plus FITC-streptavidin.  For three-color analysis, cells were stained 
with biotinylated 19E12 or H57-597 followed by FITC-streptavidin 
plus PE-conjugated  anti-CD4 and red 613-conjugated anti-CD8 
(Bethesda Research Laboratories, Gaithersburg,  MD). Dead cells 
were excluded by using propidium  iodide. 
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Thymus Grafting.  Adult C.B-17 (Thy-l.2) SCID mice were 
grafted under the kidney capsule with day 15 fetal thymuses 
taken from BALB/c (B/c) or (B6-Thy-l.1  x  B/c)F1 embryos. 
When normal donor BM cells (T depleted) were injected in- 
travenously at the time of grafting, the TG increased rapidly 
in size and remained enlarged for >115 wk (Fig. 1, a and b, 
and data not shown). The distribution of the four thymo- 
cyte subsets defined by CD4 and CD8 expression was normal 
(Fig. 2j). Injecting BM cells also caused enlargement of the 
endogenous host thymus and led to the appearance of B cells 
in the periphery. 
When SCID mice were given TG without BM cells, the 
TG were obviously enlarged at 1-3 wk posttransfer and reached 
a peak cellularity of '~2  x  107 cells at  3  wk (Fig.  1 a). 
During this time most of the cells in the grafts were typical 
CD4+8 + cells (Figs.  1 b,  and 2,  b and c).  Single-positive 
CD4 + 8-  and CD4-8 + cells were rare at 1 wk but reached 
normal levels at 2-3 wk; TCK expression was normal, with 
small numbers of TCK-  and TCR  hi cells and large numbers 
of TCK t~ cells (Fig.  3  b).  LN  of the TG mice were very 
small at  1 wk but then rapidly enlarged; nearly all of the 
cells in LN were T  cells (Figs. 1 a, and 2, k, l, and m), and 
most  expressed  a  virgin/resting  (CD45RB +)  phenotype 
(Fig. 2 o). Significantly, thymopoiesis in the TG ceased abruptly 
after 3 wk; marked atrophy ensued and cell counts decreased 
20-fold (Fig.  1 a). The proportion of CD4 + 8 + cells in the 
grafts fell sharply and these cells were almost undetectable 
after 4 wk (Figs.  1 b, and 2, d and e). At >--4 wk,  the few 
ceils recovered from the grafts (r~10  6 cells) consisted of dis- 
crete subsets of TCK-  and TCK  hi ceils, with TCR  l~ cells 
being conspicuously absent (Fig. 3 a, compare with b). The 
TCR  hi cells comprised a mixture of CD4 + 8-  and CD4- 8 + 
cells with  almost no CD4+8 + cells (Fig.  3 J~. 
Since thymopoiesis in the TG persisted for >115 wk in hosts 
supplemented with donor BM (see above), the dramatic de- 
dine in thymopoiesis seen in hosts given TG without BM 
(seen in four of five mice tested at 4 wk and nine of nine 
mice tested at 6-15 wk) provides direct support for the long 
standing notion that the seE-renewing capacity of thymic stem 
cells is limited and that normal thymopoiesis depends upon 
a constant influx of new stem cells from the marrow (see 
Introduction). 
Two unexpected findings in the TG mice require comment. 
First,  the  grafts  did  not  become  depleted  of  mature 
CD4+8 -  and CD4-8 + cells.  These cells remained in the 
grafts indefinitely (>15 wk) and, after 4 wk, showed a cu- 
rious predominance of CD8 + cells over CD4 + cells (Fig. 2, 
d and e).  Since CD8 + and CD4 + cells (but not CD4+8 + 
cells) also appeared in the endogenous thymus (Fig. 2 g, com- 
pare with a), we suspect that the presence of these mature 
T  cells reflected immigration from the peripheral lymphoid 
tissues (after initial release from the TG). In this respect, we 
have found that the SCID thymus is abnormally permeable 
to circulating T cells and that, in marked contrast to the normal 
thymus (10),  the SCID thymus rapidly accumulates mature 
T  cells, especially CD8 + cells, after intravenous injection of 
normal LN cells (C. D. Surh and J. S. Sprent, unpublished 
data). Second, it is notable that, at >--4 wk postgrafting, the 
TG contained a high proportion (up to 50%) of CD4-8- 
cells (Fig. 2, d and e). As in the endogenous SCID thymus 
(Fig. 2 h), most of these CD4-8-  cells were IL-2K + (Fig. 
2j).  Grafting with Thy-l-marked thymuses indicated that 
the late-appearing CD4-8- cells in the TG were almost en- 
tirely of host (SCID) origin (Fig. 3, d, g, and h), implying 
that the TG were eventually permeated by substantial numbers 
of defective SCID stem cells; these cells remained CD4- 8- 
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Figure 1.  Features of thymus and LN cells 
recovered from SCID mice receiving BALB/c 
TG alone (open symbols)  or TG plus BM cells 
(filled symbols). (a) Total viable cells in suspen- 
sions prepared from the TG ([7 and m) or from 
pooled inguinal,  brachial, axiUary,  and mesen- 
teric  LN  (A  and  A).  (b)  Percentage  of 
CD4+8 + ([~ and ,),  CD4+8 -  (A and A), 
and CD4-8 + (<~ and ~) cells in suspensions 
prepared from the TG; thymocytes were typed 
for CD4 and CD8 expression as described in 
Materials and Methods. Each data point is the 
mean value obtained from two to three mice; 
each mouse was tested individually. 
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Figure 2.  Cell types recovered from SCID mice given BALB/c TG. (a) Cells from normal SCID thymus. (b-e) Cells from TG of SCID mice given 
TG (without BM) 2 wk (b), 3 wk (c), 4￿9  wk (d), or 10 wk (e) before. (/) Cells from TG of SCID mice given TG plus BM cells 10 wk before. (g) 
Cells from endogenous  (host)  thymus of SCID mice given TG (without BM) 10 wk before￿9 (k) Same cells as for a. (t~ same cells as for c. (/) Same 
cells as for d. (k) LN cells from SCID mice given TG (without BM) 4.3 wk before. (l), LN cells from SCID mice given TG (without BM) 10 wk 
before. (m) Same cells as for k. (n) Normal BALB/c LN cells￿9  (o) Same cells as for k. The data shown are representative of two or more mice tested; 
see Materials and Methods  for details of staining. 
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Figure 3.  Host origin of CD4-8-  thymocytes recovered from TG of SCID mice given (B6-Thy-l.1  x  B/c)F1 fetal thymuses (without BM cells)￿9 
Cells were three-color stained for a//3 TCR, CD4, and CD8 as described in Materials and Methods.  (a) TCR expression on TG thymocytes taken 
at 8 wk postgrafring;  (b) TCR expression on TG thymocytes taken at 2 wk postgrafring;  (c) TCR expression on normal BALB/c thymus; (d) Thy-l.1 
expresslon on TG thymocytes taken at 4 wk postgrafting;  (e) CD4 vs. CD8 expression on TCR.- population in a; ~  CD4 vs. CD8 expression on 
TCR  hi population in a; (g) CD4 vs. CD8 expression on Thy-l.1 -  (host) population in d; (h) CD4 vs. CD8 ~xpression on Thy-l.1  § (donor) population 
in d. Table  1.  V~8 Expression by CD4 § Cells  from SCID Mice Given Fetal Thymus Grafts +_  Bone Marrow Cells 
Time after  No.  of  Cells 
Exp.  Mice tested  thymus  grafting  mice tested  tested 
Percent of CD4 + cells expressing: 
v~8  v#3  v85  v~11 
Normal  BALB.B (I-E-) 
Normal BALB/c (I-E +) 
BALB/c TG  +  BM "*" SCID 
BALB/c TG "-" SCID 
Normal (B6-Thy-l.1  x  B/c)FI 
(B6-Thy-l.1  x  B/c)F1 TG 
+  BM ~  SCID 
(B6-Thy-l.1  x  B/c)Ft TG 
"~ SCID 
wk 
-  3  LN  19.8  1.48  2.37  4.76 
-  3  LN  19.0  0.10  0.13  1.21 
15  2  LN  16.9  0.00  0.21  1.04 
4  2  LN  18.3  0.19  0.25  4.13 
6  2  LN  NT  NT  0.21  4.42 
10  2  LN  16.7  0.05  0.31  3.98 
15  2  LN  NT  NT  0.05  2.56 
-  2  Thy  18.4  0.13  0.13  0.44 
8  2  TG  14.7  0.29  0.16  1.10 
4  2  TG  6.4  0.16  0.47  5.65 
8  2  TG  14.1  0.17  0.24  3.70 
LN cells and thymocytes  were stained for CD4 expression  vs. VI3 expression  using dual fluorescence  and flow cytometry  (see Materials and Methods). 
The data on thymocytes  refer to mature (Jlld-) ceils (10). 
V~ Deletion.  Two groups have shown that VB deletion 
in  I-E + mice is less marked in/z-suppressed mice than in 
normal mice (11, 12). This finding suggests that VB deletion 
is at least partly under the control of B cells. The extreme 
paucity of B (B220 § ) cells in TG SCID mice (~0.2% of LN 
cells; Fig. 2 m) makes these mice a useful tool for examining 
the requirements for l-E-controlled VB deletion. As shown 
in Table 1, Exp. 1, TG SCID mice reconstituted with normal 
donor (BALB/c, I-E +) BM cells closely resembled normal 
BALB/c mice in showing marked deletion of V/~3 +, VB5 ", 
and V1511  + cells  (but  not V~8"  cells)  at  the level of LN 
CD4 + cells. Different results were found with TG mice not 
given BM cells. Except at late stages postgrafting (15 wk), 
these mice showed almost no deletion of V/~11"  cells (rela- 
tive to normal I-E-  BALB.B control mice). In marked con- 
trast,  deletion of VB3 + and V/~5  + cells was almost as ex- 
tensive as in the control I-E + mice. The selective  deletion 
of VB3 + and V/35"  cells, but not VB11 § cells,  in the TG 
mice was seen in all mice tested and was evident in the thymus 
(Table  1,  Exp. 2)  as well as in LN. 
The above data  complement  and extend the  studies  of 
Gollub and Palmer (12) on #-suppressed mice, and suggest 
that the role of mature B cells in controlling V/~ deletion 
is variable, contact with B cells apparently being critical for 
deletion of VB11 + cells but not of VB3 § or V~5 § cells (at 
least for the BALB/c background). Obtaining definitive evi- 
dence on which cell  types (presumably non-B ceils)  deter- 
mine deletion of VB3 § and VB5 § cells will probably rest 
on defining the precise tissue distribution of the I-E-associated 
mouse mammary tumor virus "coligands" recognized by these 
T  cells  (13). 
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